{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:11:11Z","timestamp":1778904671082,"version":"3.51.4"},"reference-count":6,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,5,15]]},"DOI":"10.2169\/internalmedicine.6429-25","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:08:07Z","timestamp":1759961287000},"page":"1446-1447","source":"Crossref","is-referenced-by-count":0,"title":["Reply to the Letter to the Editor: \"Underlying Mechanism of Hypothyroidism in a Patient with ATTRv Receiving Patisiran\""],"prefix":"10.2169","volume":"65","author":[{"given":"Hisatsugu","family":"Tachibana","sequence":"first","affiliation":[{"name":"Department of Neurology, Takatsuki General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuharu","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Takatsuki General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tachibana H, Ueda M, Matsushita T. Development of hypothyroidism in a patient with ATTRv amyloidosis following patisiran administration. Intern Med 65: 582-586, 2026.","DOI":"10.2169\/internalmedicine.5839-25"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Huang G, Ueda M, Tasaki M, et al. Clinicopathological and biochemical findings of thyroid amyloid in hereditary transthyretin amyloidosis with and without liver transplantation. Amyloid 24: 24-29, 2017.","DOI":"10.1080\/13506129.2016.1276440"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Koike H, Katsuno M. Transthyretin amyloidosis: update on the clinical spectrum, pathogenesis, and disease-modifying therapies. Neurol Ther 9: 317-333, 2020.","DOI":"10.1007\/s40120-020-00210-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Mimoto MS, Refetoff S. Clinical recognition and evaluation of patients with inherited serum thyroid hormone-binding protein mutations. J Endocrinol Invest 43: 31-41, 2020.","DOI":"10.1007\/s40618-019-01084-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ono R, Okada S, Aoki K, Kato H, Iwahana T, Kobayashi Y. Transthyretin amyloidosis with macro-creatine kinase. BMJ Case Rep 15: e251209, 2022.","DOI":"10.1136\/bcr-2022-251209"},{"key":"6","unstructured":"6. Kageyama Y, Saitoh T. A case of hypothyroidism associated with immunoglobulin-linked macro creatine kinase. Iryo (Jpn J Natl Med Serv) 50: 844-848, 1996."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/10\/65_6429-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:26:32Z","timestamp":1778901992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/10\/65_6429-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":6,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6429-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"6429-25"}}